Drug Trial Radar · NCT07588074
Tolerability Comparison of Flarex to Lotemax SM
Last checked: Nov 20, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
May 1, 2021
Primary completion
Jun 30, 2021
Study completion Jun 30, 2021
Sponsor
- Lead sponsor
- Harrow IncIndustry
- Sponsor type
- Industry
- Collaborators
- Eyevance Pharmaceuticals
- First posted
- May 14, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study compared the ocular tolerability of fluorometholone acetate ophthalmic suspension 0.1% (FLAREX) to loteprednol etabonate ophthalmic gel 0.38% (Lotemax SM) in adult subjects. Each subject received one drop of each product, one in each eye, in a randomized, double-masked design. Comfort, impact on vision, and palpebral conjunctival injection were evaluated at 30 seconds, 5 minutes, and 10 minutes after instillation.
Conditions
- Ocular Inflammation
- Keratoconjunctivitis
- Dry Eye Disease (DED)
- Post-operative Complications
- Kerato Conjunctivitis Sicca
- Dry Eye Syndromes
- Postoperative Complications
Interventions
Fluorometholone Acetate Ophthalmic Suspension 0.1%Drug
One drop, single instillation, in randomized eye
Loteprednol Etabonate Ophthalmic Gel 0.38%Drug
One drop, single instillation, in randomized eye
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants by Subject-rated Ocular ComfortTime frame: 30 seconds, 5 minutes, and 10 minutes after instillation
- Number of Participants by Subject-rated Impact on VisionTime frame: 30 seconds, 5 minutes, and 10 minutes after instillation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Williamson Eye Center
Baton Rouge, Louisiana
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.